References
- Pestana RC , SenS, HobbsBP, HongDS. Histology-agnostic drug development–considering issues beyond the tissue. Nat. Rev. Clin. Oncol.17(9), 555–568 (2020).
- National Cancer Institute . Targeted Cancer Therapies Fact Sheet (2022). www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet
- Park JJH , SidenE, ZorattiMJet al. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. Trials20(1), 572 (2019).
- Sanz-Garcia E , ArgilesG, ElezE, TaberneroJ. BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives. Ann. Oncol.28(11), 2648–2657 (2017).
- Higgins JPT , AltmanDG, GøtzschePCet al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ343, d5928 (2011).
- McCullagh P , NelderJ. Generalized Linear Models (2nd Edition).Chapman and Hall, London, UK (1983).
- Hartung J . An alternative method for meta-analysis. Biometrical J.41(8), 901–916 (1999).
- Hartung J , KnappG. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat. Med.20(24), 3875–3889 (2001).
- Hartung J , KnappG. On tests of the overall treatment effect in meta-analysis with normally distributed responses. Stat. Med.20(12), 1771–1782 (2001).
- R Core Team (2021) . R: The R Project for Statistical Computing. www.r-project.org/index.html (Accessed 31March2022).
- Balduzzi S , RückerG, SchwarzerG. How to perform a meta-analysis with R: a practical tutorial. Evid. Based Ment. Health22(4), 153–160 (2019).
- Gordon M , LumleyT. Forestplot: advanced forest plot using ‘grid’ graphics (2022). https://CRAN.R-project.org/package=forestplot